பர்‌ட்யூ நிறுவனம் க்கு மருந்து கண்டுபிடிப்பு News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from பர்‌ட்யூ நிறுவனம் க்கு மருந்து கண்டுபிடிப்பு. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In பர்‌ட்யூ நிறுவனம் க்கு மருந்து கண்டுபிடிப்பு Today - Breaking & Trending Today

A possible new pathway for treating epileptic seizures in patients with autism

A possible new pathway for treating epileptic seizures in patients with autism
purdue.edu - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from purdue.edu Daily Mail and Mail on Sunday newspapers.

Purdue University , United States , San Francisco , Brittany Steff , Jingliang Zhang , Kevin Bender , University Of California , Stroke Of The National Institutes Health , Showalter Research , Brain Injury Research Fund , A Foundation For Action Potential Grant , Purdue Institute For Integrative Neuroscience , Walther Cancer Foundation , Purdue Institute For Drug Discovery , Iu Simon Comprehensive Cancer Center , National Institute Of Neurological Disorders , Showalter Research Trust , Purdue Big Idea Challenge , National Institute , Neurological Disorders , National Institutes , Action Potential Grant , Purdue Institute , Drug Discovery , Integrative Neuroscience , Indiana Spinal Cord ,

Neuroscience seminar highlights technologies for brain injuries, vaccine developments

Neuroscience seminar highlights technologies for brain injuries, vaccine developments
The Purdue Center for Paralysis Research brings neurophysiological and engineering solutions to a trauma-themed seminar series, co-sponsored by Plexon. (Image provided)
WEST LAFAYETTE, Ind. – The same technology that helps treat traumatic brain injuries in athletes and soldiers may one day help doctors determine the effectiveness of vaccines on patients.
This technology is among the neuroscience innovations and research in the spotlight as Purdue University’s Center for Paralysis Research and Plexon Neurotechnology Systems present the Seminar for Neurotrauma and Diseases. The seminar series, which runs through April, features speakers from Purdue, Harvard Medical School and the medical industry. ....

United States , Riyi Shi , Purdue Mari Hulman George , Chris Adam , Andrew Klein , Most Innovative University , Purdue University , Purdue Research Foundation Office Of Technology Commercialization , Purdue University Center , Purdue Institute For Integrative Neuroscience , Harvard Medical School , Paralysis Research , Purdue University College Of Veterinary Medicine , Purdue Research Foundation , Purdue Center , Purdue Institute For Drug Discovery , College Of Veterinary Medicine , Plexon Neurotechnology Systems , Purdue Mari Hulman George Endowed Professor , Applied Neuroscience , Veterinary Medicine , Purdue Institute , Integrative Neuroscience , World War , Purdue Research Foundation Office , Purdue University College ,

New inhibitors may offer novel approach to treating deadly tuberculosis

New inhibitors may offer novel approach to treating deadly tuberculosis
Zhong-Yin Zhang, head of Purdue’s Department of Medicinal Chemistry and Molecular Pharmacology, developed highly potent and selective compounds for use in the treatment of tuberculosis. (Image provided)
WEST LAFAYETTE, Ind. – Purdue University innovators have developed highly potent and selective compounds for use in the treatment of tuberculosis, which is one of the top 10 causes of death worldwide.
The Purdue researchers developed a series of small molecule inhibitors to target one of the proteins critical for the survival of TB in infected macrophages. Protein tyrosine phosphates B (mPTPB) is a virulence factor of TB to subvert the host immune responses. ....

United States , Joseph Kasper , Chris Adam , Most Innovative University , Purdue University , Us Services , Purdue Research Foundation Office Of Technology Commercialization , Purdue Department Of Medicinal Chemistry , Ipwatchdog Institute , Purdue Research Foundationoffice Of Technology Commercializationto , Association Of Public , Purdue Research Foundation , Purdue Institute For Drug Discovery , Convergence Center , Zhong Yin Zhang , Medicinal Chemistry , Molecular Pharmacology , Purdue Institute , Purdue Research Foundation Office , Technology Commercializationto , Technology Commercialization , Discovery Park District , Economic Prosperity Universities Award , Innovative University , World Report , ஒன்றுபட்டது மாநிலங்களில் ,

Inhibitors may offer approach to treating tuberculosis

Listen to this article
WEST LAFAYETTE, Ind. â Purdue University innovators have developed highly potent and selective compounds for use in the treatment of tuberculosis, which is one of the top 10 causes of death worldwide.
The Purdue researchers developed a series of small molecule inhibitors to target one of the proteins critical for the survival of TB in infected macrophages. Protein tyrosine phosphates B (mPTPB) is a virulence factor of TB to subvert the host immune responses.
The Purdue research is published in the Journal of Medicinal Chemistry.
âThe death toll from TB is particularly high because of drug-resistant strains,â said Zhong-Yin Zhang, distinguished professor and head of Purdueâs Department of Medicinal Chemistry and Molecular Pharmacology and director of Purdue Institute for Drug Discovery. âThese inhibitors are part of a promising new approach to developing TB therapeutic agents with novel targets and mechanisms of actio ....

Purdue University , Purdue Institute For Drug Discovery , Purdue Research Foundation Office Of Technology Commercialization , Purdue Department Of Medicinal Chemistry , Zhong Yin Zhang , Medicinal Chemistry , Molecular Pharmacology , Purdue Institute , Purdue Research Foundation Office , Technology Commercialization , பர்‌ட்யூ பல்கலைக்கழகம் , பர்‌ட்யூ நிறுவனம் க்கு மருந்து கண்டுபிடிப்பு , பர்‌ட்யூ ஆராய்ச்சி அடித்தளம் அலுவலகம் ஆஃப் தொழில்நுட்பம் வணிகமயமாக்கல் , பர்‌ட்யூ துறை ஆஃப் மருத்துவ வேதியியல் , ஜாங் யின் ஜாங் , மருத்துவ வேதியியல் , மூலக்கூறு மருந்தியல் , பர்‌ட்யூ நிறுவனம் , பர்‌ட்யூ ஆராய்ச்சி அடித்தளம் அலுவலகம் , தொழில்நுட்பம் வணிகமயமாக்கல் ,

Neuroscience Seminar Highlights Technologies for Brain Injuries, Vaccine Developments | Purdue University College of Veterinary Medicine

Neuroscience Seminar Highlights Technologies for Brain Injuries, Vaccine Developments | Purdue University College of Veterinary Medicine
purdue.edu - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from purdue.edu Daily Mail and Mail on Sunday newspapers.

Riyi Shi , Purdue Mari Hulman George , Chris Adam , Purdue University Center , Andrew Klein , Purdue Research Foundation Office Of Technology Commercialization , Purdue Institute For Integrative Neuroscience , Harvard Medical School , Paralysis Research , Purdue University College Of Veterinary Medicine , Purdue Center , Purdue Institute For Drug Discovery , Purdue Research Foundation , College Of Veterinary Medicine , Neuroscience Seminar Highlights Technologies , Brain Injuries , Purdue University , Plexon Neurotechnology Systems , Purdue Mari Hulman George Endowed Professor , Applied Neuroscience , Veterinary Medicine , Purdue Institute , Integrative Neuroscience , World War , Purdue Research Foundation Office , Technology Commercialization ,